4.8 Article

Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

Roser Pinyol et al.

Summary: This study revealed higher rates of ACVR2A mutations (10%) in NASH-related hepatocellular carcinoma (HCC), along with a novel mutational signature that distinguishes NASH-HCC from HCCs of other etiologies.

JOURNAL OF HEPATOLOGY (2021)

Article Multidisciplinary Sciences

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister et al.

Summary: The study investigated the impact of NASH on immunotherapy response in HCC patients and found that NASH-HCC may be less responsive to immunotherapy. Aberrant T cell activation caused by NASH-related tissue damage led to impaired immune surveillance in HCC patients.

NATURE (2021)

Article Gastroenterology & Hepatology

Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced Liver Fibrosis

Kazuhiro Kozumi et al.

Summary: The study conducted global RNA sequencing of liver tissue from 98 NAFLD patients, identifying THBS2 as a potential biomarker for NASH and advanced fibrosis. Serum TSP-2 levels were independent predictors of NASH and advanced fibrosis, stratifying patients based on the risk of hepatic complications.

HEPATOLOGY (2021)

Article Multidisciplinary Sciences

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister et al.

Summary: The text discusses the impact of NASH on the development of HCC and the effect of immunotherapy, revealing the accumulation of exhausted and unconventionally activated CD8(+)PD1(+) T cells in NASH-affected livers. In preclinical models of NASH-induced HCC, anti-PD1 treatment led to an increase in HCC, with CD8(+) T cells contributing to this increase.

NATURE (2021)

Review Gastroenterology & Hepatology

Advances in molecular classification and precision oncology in hepatocellular carcinoma

Sandra Rebouissou et al.

JOURNAL OF HEPATOLOGY (2020)

Article Medicine, General & Internal

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Gastroenterology & Hepatology

Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction

Fasiha Kanwal et al.

GASTROENTEROLOGY (2019)

Editorial Material Oncology

Immune Exclusion-Wnt/CTNNB1 Class Predicts Resistance to Immunotherapies in HCC

Roser Pinyol et al.

CLINICAL CANCER RESEARCH (2019)

Article Surgery

Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance

Mounia S. Braza et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2018)

Article Oncology

T Cell Dysfunction in Cancer

Daniela S. Thommen et al.

CANCER CELL (2018)

Article Gastroenterology & Hepatology

Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features

Daniela Sia et al.

GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification

Julien Calderaro et al.

JOURNAL OF HEPATOLOGY (2017)

Article Biochemistry & Molecular Biology

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

Adrian Ally et al.

Article Gastroenterology & Hepatology

Genetic Landscape and Biomarkers of Hepatocellular Carcinoma

Jessica Zucman-Rossi et al.

GASTROENTEROLOGY (2015)

Review Oncology

Advances in targeted therapies for hepatocellular carcinoma in the genomic era

Josep M. Llovet et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2015)

Article Gastroenterology & Hepatology

Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres

Nora Cazzagon et al.

LIVER INTERNATIONAL (2013)

Review Gastroenterology & Hepatology

Non-viral factors contributing to hepatocellular carcinoma

Manal A. Hamed et al.

WORLD JOURNAL OF HEPATOLOGY (2013)

Article Gastroenterology & Hepatology

Thrombocytopenia Exacerbates Cholestasis-Induced Liver Fibrosis in Mice

Takahiro Kodama et al.

GASTROENTEROLOGY (2010)

Review Gastroenterology & Hepatology

Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent Advancements

Yujin Hoshida et al.

SEMINARS IN LIVER DISEASE (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

Fatty Liver Disease: MR Imaging Techniques for the Detection and Quantification of Liver Steatosis

Fiona Hughes Cassidy et al.

RADIOGRAPHICS (2009)

Article Oncology

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma

Derek Y. Chiang et al.

CANCER RESEARCH (2008)